Lisinopril Tablet
Product Images NDC 51655-995

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Lisinopril (NDC 51655-995). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Northwind Health Company, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Lisinopril (133b3fec 07f6 41f5 9c7c 50b66c4c0677 01)

Lisinopril (133b3fec 07f6 41f5 9c7c 50b66c4c0677 01)
Chemical structure diagram of Lisinopril dihydrate, showing its molecular components and bonds, including the phenyl group and various functional groups attached, as part of an FDA drug label submission.*
FDA Label Image

Label (51655 995 26 Master Bottle Label Approval Rev A 06 22)

Label (51655 995 26 Master Bottle Label Approval   Rev A 06 22)
Label for Lisinopril Tablets USP 10 mg, containing 90 tablets. The label states the product is Rx only and provides storage instructions including controlled room temperature guidance. It lists Northwind Pharmaceuticals, Inc. as the repackager and Northwind Health Company, LLC as the labeler.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.